Novo Nordisk A/S Q4 Earnings Call Highlights

Helfgott said the global GLP-1 market grew more than 30% in 2025. Novo Nordisk’s U.S. operations grew 8% and international operations grew 14% , with U.S. growth helped by “one-offs.”Hong Chow will join as EVP of Product and Portfolio Strategy starting Feb. 15, coming from Merck Healthcare where she led China and International and oversaw cardiovascular, metabolism, and endocrine portfolio work.Management also announced changes to the executive team. EVP of U.S. Operations Dave Moore and EVP of Product and ...